Chinese Journal of Ocular Fundus Diseases 2015;31(1):3-5

doi:10.3760/cma.j.issn.1005-1015.2015.01.002

Optimization of treatment outcome and exploration of new indication in anti-vascular endothelial growth factor therapy

Xun XU

Keywords

Angiogenesis inhibitors/therapeutic use; Antibodies,monoclonal/therapeutic use; Choroidal neovascularization/drug therapy; Retinal neovascularization/drug therapy

Country

China

Language

Chinese

Abstract

Since anti vascular endothelial growth factor (VEGF) therapy has recently become the first-line treatment of wet age related macular degeneration in China,as well as retinopathy of prematurity,neovascular glaucoma and macular edema secondary to diabetic retinopathy or retinal vein occlusion in other countries,It is worth thinking about that how to perform anti-VEGF treatment properly to benefit more patients.We reviewed the fields of clinical researches to explore the best role of anti-VEGF treatment in prevention and treatment of retinal disease in future.